Serum 25-Hydroxy Vitamin D and Survival in Advanced Colorectal Cancer: A Retrospective Analysis

REFERENCES

• Martins D, Wolf M, Pan D, Zadshir A, Tareen N, et al.: Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 167, 1159–1165, 2007.
   PubMed Web of Science ®Google Scholar
• Holick MF: The vitamin D deficiency pandemic and consequences for nonskeletal health: mechanisms of action. Mol Aspects Med 29, 361–368, 2008.
   PubMed Web of Science ®Google Scholar
• Lee JH, O'Keefe JH, Bell D, Hensrud DD, and Holick MF: Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol 52, 1949–1956, 2008.
   PubMed Web of Science ®Google Scholar
• Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, et al.: Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96, 1911–1930, 2011.
   PubMed Web of Science ®Google Scholar
• Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, et al.: The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96, 53–58, 2011.
   PubMed Web of Science ®Google Scholar
• Feldman D, Krishnan AV, Swami S, Giovannucci E, and Feldman BJ: The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer 14, 342–357, 2014.
   PubMed Web of Science ®Google Scholar
• Sieg J, Sieg A, Dreyhaupt J, and Schmidt-Gayk H: Insufficient vitamin D supply as a possible co-factor in colorectal carcinogenesis. Anticancer Res 26, 2729–2733, 2006.
   PubMed Web of Science ®Google Scholar
• Giovannucci E, Liu Y, and Willett WC: Cancer incidence and mortality and vitamin D in black and white male health professionals. Cancer Epidemiol Biomarkers Prev 15, 2467–2472, 2006.
   PubMed Web of Science ®Google Scholar
• Giovannucci E: Vitamin D and cancer incidence in the Harvard cohorts. Ann Epidemiol 19, 84–88, 2009.
   PubMed Web of Science ®Google Scholar
• Giovannucci E: Epidemiology of vitamin D and colorectal cancer: casual or causal link? J Steroid Biochem Mol Biol 121, 349–354, 2010.
   PubMed Web of Science ®Google Scholar
• Gorham ED, Garland CF, Garland FC, Grant WB, Mohr SB, et al.: Vitamin D and prevention of colorectal cancer. J Steroid Biochem Mol Biol 97, 179–194, 2005.
   PubMed Web of Science ®Google Scholar
• Ng K, Meyerhardt JA, Wu K, Feskanich D, Hollis BW, et al.: Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer. J Clin Oncol 26, 2984–2991, 2008.
   PubMed Web of Science ®Google Scholar
• Wu K, Feskanich D, Fuchs CS, Willett WC, Hollis BW, et al.: A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer. J Natl Cancer Inst 99, 1120–1129, 2007.
   PubMed Web of Science ®Google Scholar
• Giovannucci E: Epidemiology of vitamin D and colorectal cancer. Anticancer Agents Med Chem 13, 11–19, 2013.
   PubMed Web of Science ®Google Scholar
• Matusiak D, Murillo G, Carroll RE, Mehta RG, and Benya RV: Expression of vitamin D receptor and 25-hydroxyvitamin D3-1{alpha}-hydroxylase in normal and malignant human colon. Cancer Epidemiol Biomarkers Prev 14, 2370–2376, 2005.
   PubMed Web of Science ®Google Scholar
• Murtaugh MA, Sweeney C, Ma KN, Potter JD, Caan BJ, et al.: Vitamin D receptor gene polymorphisms, dietary promotion of insulin resistance, and colon and rectal cancer. Nutr Cancer 55, 35–43, 2006.
   PubMed Web of Science ®Google Scholar
• Slattery ML, Herrick J, Wolff RK, Caan BJ, Potter JD, et al.: CDX2 VDR polymorphism and colorectal cancer. Cancer Epidemiol Biomarkers Prev 16, 2752–2755, 2007.
   PubMed Web of Science ®Google Scholar
• Kure S, Nosho K, Baba Y, Irahara N, Shima K, et al.: Vitamin D receptor expression is associated with PIK3CA and KRAS mutations in colorectal cancer. Cancer Epidemiol Biomarkers Prev 18, 2765–2772, 2009.
   PubMed Web of Science ®Google Scholar
• Touvier M, Chan DS, Lau R, Aune D, Vieira R, et al.: Meta-analyses of vitamin D intake, 25-hydroxyvitamin D status, vitamin D receptor polymorphisms, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 20, 1003–1016, 2011.
   PubMed Web of Science ®Google Scholar
• Muindi JR, Adjei AA, Wu ZR, Olson I, Huang H, et al.: Serum vitamin D metabolites in colorectal cancer patients receiving cholecalciferol supplementation: correlation with polymorphisms in the vitamin D genes. Horm Cancer 4, 242–250, 2013.
   PubMed Web of Science ®Google Scholar
• Tangpricha V, Spina C, Yao M, Chen TC, Wolfe MM, et al.: Vitamin D deficiency enhances the growth of MC-26 colon cancer xenografts in Balb/c mice. J Nutr 135, 2350–2354, 2005.
   PubMed Web of Science ®Google Scholar
• Holt PR, Arber N, Halmos B, Forde K, Kissileff H, et al.: Colonic epithelial cell proliferation decreases with increasing levels of serum 25-hydroxy vitamin D. Cancer Epidemiol Biomarkers Prev 11, 113–119, 2002.
   PubMed Web of Science ®Google Scholar
• Krishnan AV and Feldman D: Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D. Annu Rev Pharmacol Toxicol 51, 311–336, 2011.
   PubMed Web of Science ®Google Scholar
• Murillo G, Matusiak D, Benya RV, and Mehta RG: Chemopreventive efficacy of 25-hydroxyvitamin D3 in colon cancer. J Steroid Biochem Mol Biol 103, 763–767, 2007.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Sancho JM, Larriba MJ, Ordonez-Moran P, Palmer HG, and Munoz A: Effects of 1alpha,25-dihydroxyvitamin D3 in human colon cancer cells. Anticancer Res 26, 2669–2681, 2006.
   PubMed Web of Science ®Google Scholar
• Grant WB and Holick MF: Benefits and requirements of vitamin D for optimal health: a review. Altern Med Rev 10, 94–111, 2005.
   PubMed Web of Science ®Google Scholar
• Heaney RP and Holick MF: Why the IOM recommendations for vitamin D are deficient. J Bone Miner Res 26, 455–457, 2011.
   PubMed Web of Science ®Google Scholar
• Gorham ED, Garland CF, Garland FC, Grant WB, Mohr SB, et al.: Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. Am J Prev Med 32, 210–216, 2007.
   PubMed Web of Science ®Google Scholar
• Goodwin PJ, Ennis M, Pritchard KI, Koo J, and Hood N: Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. J Clin Oncol 27, 3757–3763, 2009.
   PubMed Web of Science ®Google Scholar
• Rose AA, Elser C, Ennis M, and Goodwin PJ: Blood levels of vitamin D and early stage breast cancer prognosis: a systematic review and meta-analysis. Breast Cancer Res Treat 141, 331–339, 2013.
   PubMed Web of Science ®Google Scholar
• Peppone LJ, Rickles AS, Janelsins MC, Insalaco MR, and Skinner KA: The association between breast cancer prognostic indicators and serum 25-OH vitamin D levels. Ann Surg Oncol 19, 2590–2599, 2012.
   PubMed Web of Science ®Google Scholar
• Lee JE, Li H, Chan AT, Hollis BW, Lee IM, et al.: Circulating levels of vitamin D and colon and rectal cancer: the Physicians' Health Study and a meta-analysis of prospective studies. Cancer Prev Res (Phila) 4, 735–743, 2011.
   PubMed Web of Science ®Google Scholar
• Fakih MG, Trump DL, Johnson CS, Tian L, Muindi J, et al.: Chemotherapy is linked to severe vitamin D deficiency in patients with colorectal cancer. Int J Colorectal Dis 24, 219–224, 2009.
   PubMed Web of Science ®Google Scholar
• Giovannucci E: Epidemiological evidence for vitamin D and colorectal cancer. J Bone Miner Res 22 (Suppl 2), V81–V85, 2007.
   PubMed Web of Science ®Google Scholar
• Mezawa H, Sugiura T, Watanabe M, Norizoe C, Takahashi D, et al.: Serum vitamin D levels and survival of patients with colorectal cancer: post-hoc analysis of a prospective cohort study. BMC Cancer 10, 347, 2010.
   PubMed Web of Science ®Google Scholar
• Ng K, Sargent DJ, Goldberg RM, Meyerhardt JA, Green EM, et al.: Vitamin D status in patients with stage IV colorectal cancer: findings from Intergroup trial N9741. J Clin Oncol 29, 1599–1606, 2011.
   PubMed Web of Science ®Google Scholar
• Arneson WL and Arneson DL: Current methods for routine clinical laboratory testing of Vitamin D levels. Lab Med 44, E38–E42, 2013.
   Web of Science ®Google Scholar
• Vashi PG, Lammersfeld CA, Braun DP, and Gupta D: Serum 25-hydroxyvitamin D is inversely associated with body mass index in cancer. Nutr J 10, 51, 2011.
   PubMed Web of Science ®Google Scholar
• Fiscella K, Winters P, Tancredi D, Hendren S, and Franks P: Racial disparity in death from colorectal cancer: does vitamin D deficiency contribute? Cancer 117, 1061–1069, 2011.
   PubMed Web of Science ®Google Scholar
• Hershberger PA, McGuire TF, Yu WD, Zuhowski EG, Schellens JH, et al.: Cisplatin potentiates 1,25-dihydroxyvitamin D3-induced apoptosis in association with increased mitogen-activated protein kinase kinase kinase 1 (MEKK-1) expression. Mol Cancer Ther 1, 821–829, 2002.
   PubMed Web of Science ®Google Scholar
• Light BW, Yu WD, McElwain MC, Russell DM, Trump DL, et al.: Potentiation of cisplatin antitumor activity using a vitamin D analogue in a murine squamous cell carcinoma model system. Cancer Res 57, 3759–3764, 1997.
   PubMed Web of Science ®Google Scholar
• Moffatt KA, Johannes WU, and Miller GJ: 1Alpha,25dihydroxyvitamin D3 and platinum drugs act synergistically to inhibit the growth of prostate cancer cell lines. Clin Cancer Res 5, 695–703, 1999.
   PubMed Web of Science ®Google Scholar
• Milczarek M, Rosinska S, Psurski M, Maciejewska M, Kutner A, et al.: Combined colonic cancer treatment with vitamin D analogs and irinotecan or oxaliplatin. Anticancer Res 33, 433–444, 2013.
   PubMed Web of Science ®Google Scholar